Home › Companies › PTC Therapeutics, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and PTC Therapeutics, Inc.’s Form 8-K, filed 2026-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore PTC Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are PTC Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jessica Chutter | 71,945,515 | -- | -- | 737,780 | 3,858,311 | Majority: yes |
| Elect Director: Matthew B. Klein, M.D., M.S., F.A.C.S. | 71,550,878 | -- | -- | 1,132,417 | 3,858,311 | Majority: yes |
| Elect Director: Stephanie S. Okey, M.S. | 68,902,707 | -- | -- | 3,780,588 | 3,858,311 | Majority: yes |
| Elect Director: Jerome B. Zeldis, M.D., Ph.D. | 69,821,943 | -- | -- | 2,861,352 | 3,858,311 | Majority: yes |
Source: PTC Therapeutics, Inc., Form 8-K, filed with the SEC on 2026-06-05 — read the filing on EDGAR.
Each item below shows how the 355 asset managers that disclosed a PTC Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PTC Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
99% fund support · no official result
The 346 asset managers below cast 99% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 11,815,886 | 1,118 | 0 | 0 | For |
| Vanguard | 11,591,653 | 8 | 0 | 0 | For |
| Janus Henderson | 11,209,345 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 7,746,415 | 0 | 0 | 0 | For |
| Fidelity | 4,657,017 | 0 | 0 | 0 | For |
| State Street | 4,053,984 | 0 | 0 | 0 | For |
| Wellington | 3,445,221 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,217,194 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 1,593,575 | 0 | 0 | 0 | For |
| Charles Schwab | 1,412,755 | 0 | 0 | 0 | For |
| Invesco | 1,381,969 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,099,372 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,080,589 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| DE Shaw | 958,390 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 918,846 | 0 | 0 | 0 | For |
| T. Rowe Price | 901,505 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 711,457 | 0 | 0 | 0 | For |
| Northern Trust | 693,964 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 681,917 | 0 | 0 | 0 | For |
| Nuveen | 650,233 | 0 | 0 | 0 | For |
| Boston Partners | 633,462 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| Loomis Sayles | 626,105 | 0 | 0 | 0 | For |
Showing the 25 largest of 346 asset managers. See all 346 in the interactive database.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Jerome B. Zeldis, M.D., Ph.D.”): 69,821,943 for, 2,861,352 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,882,024 outstanding shares: 84% for, 3% withheld (88% of the company cast a for/withheld vote).
The 110 asset managers below cast 100% of the shares they voted on this item FOR (36,152,559 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,366 | 0 | 20 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 0 | 146 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 324,181 | 0 | Abstain |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Abstain |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 132,509 | 0 | 59,080 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Combines 7 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Jessica Chutter”): 71,945,515 for, 737,780 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,882,024 outstanding shares: 87% for, 0.9% withheld (88% of the company cast a for/withheld vote).
The 110 asset managers below cast 100% of the shares they voted on this item FOR (36,682,095 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,382 | 0 | 4 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,644,111 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Abstain |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Matthew B. Klein, M.D., M.S., F.A.C.S.”): 71,550,878 for, 1,132,417 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,882,024 outstanding shares: 86% for, 1% withheld (88% of the company cast a for/withheld vote).
The 110 asset managers below cast 100% of the shares they voted on this item FOR (36,681,947 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,380 | 0 | 6 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 0 | 146 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Abstain |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Combines 7 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Stephanie S. Okey, M.S.”): 68,902,707 for, 3,780,588 withheld, per its Form 8-K filed 2026-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,882,024 outstanding shares: 83% for, 5% withheld (88% of the company cast a for/withheld vote).
The 110 asset managers below cast 100% of the shares they voted on this item FOR (36,059,086 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,900,994 | 0 | 12,393 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,644,111 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 324,181 | 0 | Abstain |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Abstain |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 132,509 | 0 | 59,080 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
99.9% fund support · no official result
The 109 asset managers below cast 99.9% of the shares they voted on this item FOR (36,931,346 for, 33,510 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,384 | 2 | 0 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 146 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 284,589 | 0 | 0 | 0 | For |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
100% fund support · no official result
The 6 asset managers below cast 100% of the shares they voted on this item FOR (154,313 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SECTOR GAMMA AS | 59,189 | 0 | 0 | 0 | For |
| Empower | 57,675 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 16,783 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 13,361 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 7,290 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 15 | 0 | 0 | 0 | For |
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (74,473 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 57,675 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 16,783 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 15 | 0 | 0 | 0 | For |
Ranked by the number of PTC Therapeutics, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 82,882,024 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 14.26% |
| 2 | Vanguard | 13.99% |
| 3 | Janus Henderson | 13.52% |
| 4 | RTW INVESTMENTS, LP | 9.35% |
| 5 | Fidelity | 5.62% |
| 6 | State Street | 4.89% |
| 7 | Wellington | 4.16% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.68% |
| 9 | JANUS INVESTMENT FUND | 2.30% |
| 10 | Hood River Capital Management LLC | 1.92% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 15.62% | 13F |
| Vanguard Group | 10.62% | 13F |
| RTW Investments L.P. | 8.96% | DEF14A |
| JANUS HENDERSON GROUP PLC | 8.68% | 13G |
| Vanguard Portfolio Management | 5.88% | 13G |
| STATE STREET CORPORATION | 5.07% | 13G |
| Wellington Management | 4.76% | 13F |
| The Toronto-Dominion Bank | 3.65% | 13G |
| Michael Schmertzler | 2.11% | DEF14A |
| D.E. Shaw | 1.98% | 13F |
Percentages above are of 82,882,024 shares outstanding, as reported by PTC Therapeutics, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PTC Therapeutics, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At PTC Therapeutics, Inc.'s shareholder meeting held 2026-06-02, in the 2025-2026 proxy season, 355 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,012 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PTC Therapeutics, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval on a non-binding, advisory basis, of the Company's named executive officer… — the reporting funds cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
PTC Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).